Red biotechnology, also known as medical biotechnology, refers to the branch of biotechnology that focuses on the application of genetic engineering and molecular biology to develop innovative medical products and treatments. Unlike green biotechnology, which revolves around agriculture, or white biotechnology, which centers on industrial applications, red biotechnology is dedicated to advancements in healthcare. This field encompasses the development of pharmaceuticals, diagnostic tests, gene therapies, and vaccines. Researchers in red biotechnology work on understanding and manipulating biological processes at the molecular level to create novel medical solutions. Examples of red biotechnology applications include the production of genetically engineered drugs, stem cell therapies, and personalized medicine tailored to an individual's genetic makeup. The continuous progress in red biotechnology holds promise for groundbreaking advancements in medical science and the improvement of healthcare outcomes.
Title : Improving health in over 40,000 patients: The impact of nanomedicine fighting antibiotic resistant infections
Thomas J Webster, Brown University, United States
Title : Renewed novel biotech ideas, with bioreactor bioengineering economic impact
Murray Moo Young, University of Waterloo, Canada
Title : Osmotic lysis–driven Extracellular Vesicle (EV) engineering
Limongi Tania, University of Turin, Italy
Title : Predicting wound closure and future segmentation masks in wound healing assays
Alfredo De Cillis, Univeristy of Salento, CNR Nanotec, Italy
Title : Scientist’s computational lawyer
Julia Sidorova, Instituto Carlos III de Salud (CIBER-EHD), Spain
Title : Evaluating cell compatibility and subcutaneous host response of silk fibroin–chitosan plug composites as potential resorbable implants
Luis Jesus Villarreal Gomez, Universidad Autonoma de Baja California, Mexico